Breaking News
-
Breaking News | Industry News
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Propanc, University of Jaén, Spain Enter Collaboration
For the provision of research services and scientific technical advice for the Company's POP1 drug discovery program09.19.18
-
Industry News | Promotions & Moves
Astellas Announces Key Promotion
Geoff Towle has been promoted to vice president, Oncology Marketing, Astellas US09.19.18
-
Bio News | Collaborations & Alliances | Industry News
Molecular Templates, Takeda Enter Agreement
For the joint development of CD38-targeted engineered toxin bodies (ETBs) for the treatment of patients with diseases09.19.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
APEIRON & LDC Enter Partnership
To perform drug discovery activities to optimize and develop novel small molecules addressing immune checkpoints09.19.18
-
APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
Evonik Completes €36M Expansion
Adds HPAPI, mPEGs and continuous processing at multiple production sites in the U.S. and Europe09.19.18
-
Breaking News | Drug Delivery | Industry News
Zosano Pharma Completes Registration Batches of M207
Lead candidate incorporates Adhesive Dermally-Applied Microneedle technology09.19.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Dyadic, Sanofi in Research Collaboration
To explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest09.18.18
-
Bio News | Collaborations & Alliances | Industry News
Neurimmune Achieves Milestone in Ono Collaboration
Focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases09.18.18
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
AstraZeneca Joins Horizon's Genomics Discovery Initiative
Horizon Discovery's Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform09.18.18
-
APIs | Breaking News | Facilities | Industry News
Lonza Launches Early-Intermediates Supply Initiative for Small-Molecule APIs
Addresses concerns regarding over-dependence on regional supply of pharma ingredients to the Western Pharma industry09.18.18
-
Industry News
WuXi Biologics Executive Receives Service Award
Dr. Chiang Syin, chief quality officer, received the Foreign Post Service Award for his contributions in the FDA China Office09.18.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Fate & ONO Enter Development Partnership
For the joint development and commercialization of two off-the-shelf CAR-T cell product candidates09.18.18
-
Breaking News | Capsules | Collaborations & Alliances | Packaging & Tracking
PCI, CSP Technologies in Exclusive Activ-Blister Alliance
To provide clinical trials and stability testing utilizing Activ-Blister packaging solutions09.17.18
-
Breaking News | Clinical Trials | CRO News | Drug Development | Information Technology
PAREXEL, Datavant in RWE Alliance
Aims to link healthcare data from a variety of real-world and clinical study data sources to improve drug development09.17.18
-
Breaking News | Collaborations & Alliances | Drug Development
Agenus Achieves Incyte Milestone
Initiation of a Phase I trial of INCAGN2385 triggers $5M payment09.17.18
-
Bio News | Industry News | Promotions & Moves
Metrion Announces Executive Appointments
Dr Edward Stevens joins as head of Drug Discovery, and Dr Andrew Lightfoot as head of Medicinal Chemistry & Discovery Funding09.17.18
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Laboratory Testing
BIA Separations Opens New Upstream Processing Facility
New lab will support integrated optimization of upstream and downstream process development09.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Evotec, Almirall Sign Research Agreement
To discover and develop first-in-class therapeutics through a novel approach to disrupt cell signalling09.17.18
-
Industry News
Regeneron to Invest $800M in Rensselaer
To expand its lab space, manufacturing capacity and warehouse facilities; will create 1,500 new jobs09.14.18
